Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of vaccinated
individuals is increasingly common but rarely results in severe disease, likely due to the …
individuals is increasingly common but rarely results in severe disease, likely due to the …
The humoral response of patients with cancer to breakthrough COVID-19 infection or the fourth BNT162b2 vaccine dose
I Cohen, S Campisi-Pfinto, O Rozenberg… - The …, 2023 - academic.oup.com
Abstract Since January 2022 in Israel, high-risk populations with underlying health
conditions were advised to receive a fourth dose of the BNT162b2 vaccine (Pfizer …
conditions were advised to receive a fourth dose of the BNT162b2 vaccine (Pfizer …
[HTML][HTML] Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of …
SARS-CoV-2 infection of vaccinated individuals is increasingly common but rarely results in
severe disease, likely due to the enhanced potency and accelerated kinetics of memory …
severe disease, likely due to the enhanced potency and accelerated kinetics of memory …
Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough …
Background We sought to identify potential antigens for discerning between humoral
responses elicited after vaccination with CoronaVac (a severe acute respiratory syndrome …
responses elicited after vaccination with CoronaVac (a severe acute respiratory syndrome …
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
A Agbarya, I Sarel, T Ziv-Baran, O Schwartz… - Diseases, 2023 - mdpi.com
The BNT162b2 vaccine is globally used for preventing morbidity and mortality related to
COVID-19. Cancer patients have had priority for receiving the vaccine due to their …
COVID-19. Cancer patients have had priority for receiving the vaccine due to their …
Airway and Systemic Immune Responses Following the Third COVID-19 Vaccination in COPD Patients
T Southworth, N Jackson, D Singh - International Journal of …, 2023 - Taylor & Francis
Introduction Booster vaccinations are required to maintain protection against COVID-19.
COPD patients are at higher risk of developing severe illness following SARS-CoV-2 …
COPD patients are at higher risk of developing severe illness following SARS-CoV-2 …
Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: Implications of immune imprinting and interference
MJ Choi, YJ Yu, JW Kim, HJ Ju, SY Shin… - Clinical Microbiology …, 2024 - Elsevier
Objectives Concomitant COVID-19 and influenza vaccination would be an efficient strategy.
Although the co-administration of monovalent COVID-19 and influenza vaccinations showed …
Although the co-administration of monovalent COVID-19 and influenza vaccinations showed …
Serial infection with SARS-CoV-2 Omicron BA. 1 and BA. 2 following three-dose COVID-19 vaccination
HR Lapointe, F Mwimanzi, PK Cheung, Y Sang… - Frontiers in …, 2022 - frontiersin.org
SARS-CoV-2 Omicron infections are common among individuals who are vaccinated or
have recovered from prior variant infection, but few reports have immunologically assessed …
have recovered from prior variant infection, but few reports have immunologically assessed …
B cell responses to SARS-CoV-2
AK Zaidi, S Bajpai, P Dehgani-Mobaraki - Progress in Molecular Biology …, 2024 - Elsevier
This chapter provides an overview of B cell responses in COVID-19, highlighting the
structure of SARS-CoV-2 and its impact on B cell immunity. It explores the production and …
structure of SARS-CoV-2 and its impact on B cell immunity. It explores the production and …
Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
M Toda, A Yoshifuji, T Nakayama, S Mise-Omata… - Vaccines, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) following primary immunization (breakthrough
infection) has been reported in hemodialysis patients; however, their post-infection immune …
infection) has been reported in hemodialysis patients; however, their post-infection immune …